Haemophilia · 2020 · 10 citations · 7 references
Life SciencesHematologyImmunologyClinical ImmunologyImmunotherapyMonoclonal AntibodiesAutoimmune DiseasesAutoimmune Hematologic DiseaseCytotoxic T Lymphocyte ResponsesImmunomodulatory DrugsImmunosuppressionMonoclonal Antibody TherapyAlemtuzumab UseB-cell Depleting AgentsSecondary Autoimmune Hematologic DisordersT-cell Mediated Immunity
Treatment with alemtuzumab leads to a prolonged depletion of T-and B cells, natural killer cells, dendritic cells and monocytes. 1
7
Therapeutic challenges in acquired factor VIII deficiency
Peter W. Collins · Hematology · 2012 · 43 citations · Full text
Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis
Georgia McCaughan, Jennifer Massey, Ian Sutton et al. · BMJ Case Reports · 2017 · 22 citations · Full text